PubRank

J P SOULIER

Author PubWeight™ 47.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Differentiation of hemophilia into two groups; a study of thirty-three cases. N Engl J Med 1953 1.42
2 [Preparation of a fraction rich in prothrombin, proconvertin, Stuart factor and antihemophilic factor B (P.P.B. fraction)]. Pathol Biol (Paris) 1959 1.39
3 [Therapeutic results in the use of human serum gamma globulins; survey of 6, 602 cases. I. Main indications for their use in infections diseases]. Presse Med 1958 1.39
4 [Deficiency of antihemophilic factor A in a girl associated with bleeding disorder]. Rev Hematol 1953 1.34
5 [Not Available]. Rev Hematol 1949 1.25
6 [Differential characteristics of Hageman & P.T.A. factors; role of contact in the initial phase of coagulation]. Rev Fr Etud Clin Biol 1958 1.21
7 [Umbilical cord blood; complete study of its coaguability, comparison with maternal blood]. Etudes Neonatales 1952 1.20
8 [Fatal hemorrhagic syndromes with total incoagulability and with fibrinolysis; in pulmonary exeresis]. Rev Hematol 1952 1.15
9 [Analytical study on Quick test; determination of prothrombin, proconvertin, and proaccelerin]. Sang 1952 1.15
10 Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man. J Lab Clin Med 1959 1.14
11 [Not Available]. Sem Hop 1948 1.14
12 Hageman trait and PTA deficiency; the role of contact of blood with glass. Br J Haematol 1959 1.13
13 Measurement of thromboplastic factors and profactors in plasma. I. Deficits in thromboplastin; study of reagents; measurements of antihemophilic and of platelet activities. J Lab Clin Med 1953 1.13
14 [Treatment of hemophilia B with a plasma fraction rich in antihemophilic B factor (P.P.B.)]. Pathol Biol (Paris) 1959 1.11
15 [Grave hemorrhages during thoracic surgery from blood incoagulability due to fibrinolysis]. Mem Acad Chir (Paris) 1951 1.03
16 A new adsorption agent for coagulation factors. J Clin Pathol 1959 1.01
17 [Electron microscope study of lymphoid leukemia with intracytoplasmic crystals]. Rev Hematol 1960 0.96
18 [Determinations of properdin; technical study]. Rev Fr Etud Clin Biol 1957 0.95
19 [Technical modifications of the in vitro heparin tolerance test]. Sem Hop 1951 0.93
20 [Thromboplastin formation in platelet disorders; study of 34 cases by Biggs and Douglas test]. Acta Haematol 1955 0.90
21 [Willebrand-Jürgens syndrome and thrombopathies; study of 66 cases; attempt at classification]. Rev Hematol 1954 0.90
22 The "in vitro" heparin tolerance test in the control of dicumarol therapy. Acta Med Scand 1951 0.90
23 [Heparin tolerance test in vitro in hemorrhagic syndromes and thrombosis]. Sem Hop 1950 0.89
24 [Action of proteolytic enzymes on whole blood in vitro; alterations in coagulation factors and in complement]. Sem Hop 1956 0.88
25 [Preparation of a human plasmatic fraction rich in factor VIII (antihemophilic A) and poor in fibrinogen]. Nouv Rev Fr Hematol 1962 0.86
26 [Physiopathology of hemorrhage in thrombocythemia; study of hemostasis in 27 patients]. Sang 1957 0.86
27 [Heparin tolerance test in vitro; hypocoagulability test, its application in diagnosis of hemorrhagic syndromes; hypercoagulability test, its application in the diagnosis of thrombosis]. Rev Hematol 1950 0.86
28 [Pathological variations of complement and properdin in man]. Acta Haematol 1959 0.85
29 [New data on the Hageman and P.T.A. factors and on the "contact"]. Rev Fr Etud Clin Biol 1959 0.85
30 [Fatal hemorrhagic syndromes with total incoagulability by defibrination and with fibrinolysis following abortion by injection of Javelle water; problem of defibrination in obstetrics and gynecology]. Rev Hematol 1952 0.85
31 [New diagnostic method in hemophilia; determination of antihemophilic factors A and B]. Sang 1953 0.84
32 [Alteration of coagulation factors in fibrinolysis in vivo; value of proaccelerin deficiency in diagnosis of defaced or latent proteolysis]. Sem Hop 1956 0.82
33 [Hemorrhagic syndrome with fibrinolysis associated with cancer of the prostate]. Presse Med 1955 0.81
34 [A new adsorbant for coagulation factors: bentonite]. Rev Hematol 1959 0.81
35 [CONGENITAL DEFICIENCY OF THE FIBRIN STABILIZING FACTOR (FACTOR XIII). STUDY OF 2 CASES]. Nouv Rev Fr Hematol 1964 0.81
36 [A case of congenital hypoconvertinemia]. Sang 1955 0.80
37 [Biological study of two cases of congenital afibrinogenemia]. Rev Hematol 1955 0.80
38 [Congenital proaccelerin deficiency (factor V); various new data]. Thromb Diath Haemorrh 1958 0.79
39 The effect of intravenous injection of trypsin inhibitor on the coagulation of blood. Blood 1948 0.79
40 [Electrophoretic study of 86 cases of proteinuria (albuminuria); proteinuria in myeloma and nephropathy]. Presse Med 1953 0.79
41 [Not Available]. Sang 1954 0.78
42 [Test of platelet-activity of the serum]. Rev Fr Etud Clin Biol 1957 0.78
43 [Half-life of true prothrombin (factor II)]. Nouv Rev Fr Hematol 1963 0.78
44 [Separation of fibrinogen and of the antihemophilic factor A]. Rev Hematol 1958 0.77
45 [Antihemophilic B factor deficiency with prolongation of bleeding time]. Sang 1957 0.77
46 Study of prothrombin consumption; practical interest for the diagnosis of hemorrhagic diseases; study of 89 cases. Acta Med Scand 1950 0.77
47 [Hageman factor deficiency]. Sang 1957 0.77
48 [Study of a case of congenital hypoprothrombinemia]. Nouv Rev Fr Hematol 1963 0.76
49 Inhibitors of blood coagulation. 4. Natural inhibitors. Thromb Diath Haemorrh 1962 0.76
50 [Not Available]. Bull Mem Soc Med Hop Paris 1955 0.75
51 [Preparation of a serum fraction rich in convertin (VII), Stuart factor (X) and antihemophilic B factor (IX). Fraction B.S.C. Experimental study in the rabbit]. Nouv Rev Fr Hematol 1962 0.75
52 [Changes in Ca++ in massive transfusions and in extracorporeal circulation using citrated blood]. Rev Hematol 1959 0.75
53 [ON THE MANUFACTURING AND USE OF BLOOD COAGULATION FACTOR CONCENTRATES FROM THE HUMAN PLASMA]. Z Gesamte Inn Med 1965 0.75
54 [Polycythemias]. Presse Med 1958 0.75
55 [Not Available]. Clinique (Paris) 1948 0.75
56 [A new method for determining ionized calcium using a blood coagulation system. II. Results]. Presse Med 1958 0.75
57 [Study of thrombosis; indications and use of anticoagulants in the treatment of thrombosis]. Sem Hop 1950 0.75
58 [Antihemophilic A fractions]. Sem Hop Ther Paris 1961 0.75
59 [Use of the anticoagulant solution Ed-glu-gate magnesium in open heart surgery]. Bibl Haematol 1962 0.75
60 [Fractions of human plasma rich in factor IX (anthemophilic factor B)]. Pathol Biol (Paris) 1959 0.75
61 [Use of injectable fibrinogen in therapy]. Sem Hop 1956 0.75
62 [Not Available]. Sem Hop 1948 0.75
63 [BLOOD COAGULATION]. Cah Coll Med Hop Paris 1965 0.75
64 [Hemorrhagic complications connected with massive transfusions]. Presse Med 1959 0.75
65 [Treatment of hemophilia A by coagulant fractions (fractions I-A and I-F)]. Pathol Biol (Paris) 1959 0.75
66 [Therapeutic use of gamma globulin]. Sem Hop 1956 0.75
67 [A constitutional hemorrhagic disease characterized by isolated prolongation of the bleeding time (Willebrand's disease; study of 9 cases)]. Rev Hematol 1950 0.75
68 [Surgery in the hemophilic. I. Fundamental biological data]. Anesth Analg (Paris) 1963 0.75
69 [Mortal peroperative hemorrhage without fibrinolysis during pulmonary decortication; possible role of injected citrates]. Poumon 1954 0.75
70 [Thrombosis factors and the mechanism of action of anticoagulants on hemostasis]. Therapie 1955 0.75
71 [Use of human plasma gamma globulins in prevention of measles; results of 1,259 cases]. Presse Med 1956 0.75
72 [Selling of blood by the cubic centimeter]. Transfusion (Paris) 1961 0.75
73 [SEROTONIN AND PLATELETS]. Pathol Biol (Paris) 1964 0.75
74 [WHAT RECENT MODIFICATIONS HAVE BEEN CONTRIBUTED TO THE TREATMENT OF ACUTE LEUKOSIS?]. Presse Med 1965 0.75
75 [Preparation of a plasma free of the thromboplastin factor of platelet origin]. Rev Hematol 1958 0.75
76 [The protamine index in disorders of hemostasis; its clinical value; its biological significance]. Sem Hop 1951 0.75
77 [Not Available]. Bull Mem Soc Med Hop Paris 1949 0.75
78 [Necessity of a laboratory]. Concours Med 1950 0.75
79 [Nomenclature of coagulation factors]. Rev Fr Etud Clin Biol 1957 0.75
80 [Hemostatic tests in the study of thrombopenic purpuras]. Sang 1957 0.75
81 [METABOLISM OF FIBRINOGEN]. Nouv Rev Fr Hematol 1965 0.75
82 [The National Center for Blood Transfusion]. Tech Hosp Med Soc Sanit 1955 0.75
83 [Problems of a medical and sanitary nature presented by the Agadir catastrophe]. Presse Med 1960 0.75
84 [Physiopathology of hemorrhages]. Presse Med 1950 0.75
85 [A new case of congenital thrombocytic hemorrhagic dystrophy]. Presse Med 1952 0.75
86 [Indications for serum albumin therapy]. Sem Hop 1957 0.75
87 [The physiology of hemostasis and the large hemorrhagic syndromes]. Rev Fr Odontostomatol 1953 0.75
88 [Separation of fibrinogen and of antihemophilic factor A. II. With the aid of bentonite]. Pathol Biol (Paris) 1959 0.75
89 Chemical, clinical and immunological studies on the products of human plasma fractionation; the coagulation defect in hemophilia; the effect in vitro and in vivo on the coagulation time in hemophilia of a prothrombin and fibrinogen-free normal plasma and its derived protein fractions. J Clin Invest 1946 0.75
90 [Optimum quantity of blood to collect in a flask]. Transfusion (Paris) 1961 0.75
91 [Treatment of hemgrrhagic syndromes associated with blood coagulation disorders]. Cah Coll Med Hop Paris 1962 0.75
92 [Supervision of dicoumarin therapy. Study of the different laboratogs tests]. Presse Med 1962 0.75
93 [Not Available]. Rev Hematol 1946 0.75
94 [Myeloid leukemia and radiotherapy]. Concours Med 1951 0.75
95 [Surgery of patients with hemorrhagic tendency]. Presse Med 1956 0.75
96 [Blood coagulation]. Presse Med 1957 0.75
97 [Artificial hibernation]. Afr Fr Chir 1954 0.75
98 [Society of Hemophiliacs]. Rev Prat 1956 0.75
99 [Hemorrhagic syndromes with isolated attacks of capillary resistance]. Sem Hop 1950 0.75
100 [Not Available]. Bull Mem Soc Med Paris (1907) 1950 0.75
101 [DOES THE RECENT ISOLATION OF ENZYMATIC DEFICIENCIES OF THE ERYTHROCYTES COMPRISE PRACTICAL RESULTS?]. Presse Med 1963 0.75
102 [Thrombin time in liver diseases]. Rev Int Hepatol 1957 0.75
103 [Therapeutic indications in anemia]. Presse Med 1958 0.75
104 [HOW TO DISCOVER THE CAUSE OF A POLYGLOBULIA]. Presse Med 1965 0.75
105 [Treatment of thromboses with anticoagulants]. Ann Soc Angeiol Histopathologie 1951 0.75
106 [Incoagulability of blood due to afibrinogenemia]. Presse Med 1952 0.75
107 [THE ENZYMATIC ACTION OF THROMBIN ON FIBRINOGEN]. Ann Biol Clin (Paris) 1964 0.75
108 [Control of coagulation during treatment with the artificial kidney; importance of protamine index]. Rev Med Liege 1958 0.75
109 [Not Available]. Rev Hematol 1958 0.75
110 [Coagulant fractions containing factors adsorbable on tricalcium phosphate]. Sem Hop Ther Paris 1962 0.75
111 [Comments on Mr. R. Ardry's report on gamma globulin, presented on May 19, 1954]. Therapie 1954 0.75
112 [Retraction of the blood clot; its physiologic and clinical significance according to A. J. Quick]. Presse Med 1951 0.75
113 [HALF-LIFE OF TRUE PROTHROMBIN (FACTOR II)]. Bibl Haematol 1964 0.75
114 [Constitutional hemorrhagic diatheses with lengthening of bleeding time without thrombocytopenia (study of 65 cases)]. Haematologica 1955 0.75
115 [On hematological examination during pregnancy]. Concours Med 1951 0.75
116 [Purification of prothrombin by bentonite. I. Preparation of purified prothrombin]. Pathol Biol (Paris) 1959 0.75
117 [Introduction to the treatment of hemorrhagic syndromes by transfusion of blood or its derivatives]. Rev Pathol Gen Physiol Clin 1954 0.75
118 [Complete failure of vitamin B12 in a case of familial hemophilia]. Rev Hematol 1953 0.75
119 [Stabilization of the P. P. B. fraction]. Pathol Biol (Paris) 1959 0.75
120 [INDICATIONS FOR FRESH BLOOD AND PRESERVED BLOOD IN DEFICIENCIES OF BLOOD COAGULATION FACTORS]. Transfusion (Paris) 1964 0.75
121 [THE NEW INSTITUT DE CANC'EROLOGIE ET D'IMMUNOG'EN'ETIQUE AT VILLEJUIF]. Presse Med 1965 0.75
122 ["COAGULANT" FRACTIONS CONTAINING COAGULATION FACTORS ADSORBABLE BY TRICALCIC PHOSPHATE]. Presse Med 1964 0.75
123 [Acute hemorrhagic syndromes with coagulation disorders]. Rev Hematol 1952 0.75
124 [Appearance of an antithrombin following thrombin injections in a hemophilic having presented a circulating anticoagulant]. Rev Hematol 1953 0.75
125 [Practical problems presented to blood transfusion centers by extracorporeal circulation]. Rev Hyg Med Soc 1962 0.75
126 [Blood coagulation]. Presse Med 1957 0.75
127 [Thromboses & emboliin surgery; thrombosis factors & role of anticoagulants]. Poumon Coeur 1959 0.75
128 [Purification of prothrombin by bentonite. II. Properties of purified prothrombin]. Pathol Biol (Paris) 1959 0.75
129 [Prolongation of clotting time combined with a deficiency of anti-hemolytic factor A]. Rev Fr Etud Clin Biol 1956 0.75
130 [Therapeutic results of gamma globulins from human plasma: study of 6602 cases. II. Secondary indications, various indications]. Presse Med 1958 0.75
131 [Acute idiopathic avitaminoses K and their treatment with vitamin K 1]. Sem Hop Ther Paris 1960 0.75
132 [Thromboplastic activity in blood & preserved plasma]. Bibl Haematol 1958 0.75
133 [Deficiency of 3d plasma prothromboplastic factor: relation between PTA & Hageman factor]. Thromb Diath Haemorrh 1958 0.75
134 [Hemorrhagic syndromes with isolated impairment of capillary resistance; study of 38 cases]. Sang 1950 0.75
135 [Hypercoagulability]. Rev Fr Etud Clin Biol 1956 0.75
136 [Physico-chemical properties of the principal plasma proteins]. Pathol Biol (Paris) 1961 0.75
137 [HOW TO PREPARE A HEMOPHILIC FOR A SURGICAL OPERATION]. Presse Med 1965 0.75
138 [Not Available]. Presse Med 1949 0.75
139 [In vitro heparin tolerance test in the control of di-coumarol therapy]. Presse Med 1950 0.75
140 [Vascular fragility and production of estroids by adrenal cortex in children]. Sem Hop 1954 0.75
141 [Disorders of the blood composition in acute leukemias; biological and therapeutic study]. Sang 1950 0.75
142 [Hemolytic complications of blood transfusions caused by iso-antibodies]. Ann Biol Clin (Paris) 1962 0.75
143 [Not Available]. Sem Hop 1948 0.75
144 [Value of anticoagulants in the treatment of pulmonary emboli]. Presse Med 1957 0.75
145 [Heparin tolerance test in vitro; its technique its clinical interest]. Ann Biol Clin (Paris) 1952 0.75
146 [Study of the frequency of transfusion hepatitis after transfusion of plasma in hemophiliacs]. Presse Med 1958 0.75
147 [Surgery in patients with hemorrhagic tendency]. Presse Med 1956 0.75
148 [Statistical survey on the therapeutic results obtained with the aid of injectable human fibrinogen]. Pathol Biol (Paris) 1959 0.75
149 [Not Available]. Rev Fr Etud Clin Biol 1956 0.75
150 [Problems of the production of serum tests of human origin in the determination of blood groups in France]. Rev Hyg Med Soc 1958 0.75
151 [Preparation of an anti-hemophilic A fraction from standard ACD plasma]. Thromb Diath Haemorrh 1962 0.75
152 [Complications of blood transfusion]. Presse Med 1960 0.75
153 [Not Available]. Rev Prat 1956 0.75
154 [Not Available]. Paris Med 1950 0.75
155 [USE OF THE P.P.B. PREPARATION IN THE TREATMENT OF HEMORRHAGIC DIATHESIS WITH CONGENITAL DEFICIENCY OF COAGULATION FACTORS]. Pol Tyg Lek 1963 0.75
156 [Statistical study of 459 cases of hemorrhagic syndromes]. Sem Hop 1950 0.75
157 [5th International Congress on Blood Transfusion in Paris, 13-19 September 1954]. Rev Hyg Med Soc 1955 0.75
158 [Statistical study of the principal biological data in 331 cases of hemophilia]. Hemostase 1962 0.75
159 [Control of coagulation during the use of a artificial kidney; significance of the protamine index]. Brux Med 1958 0.75
160 [THE USE OF INJECTABLE FIBRINOGEN IN SURGERY AND OBSTETRICS]. Sangre (Barc) 1963 0.75
161 [Acquired thrombopenia in childhood; study of 22 cases]. Arch Fr Pediatr 1951 0.75
162 [New method for the determination of ionized calcium using a coagulating system. I. Technic]. Presse Med 1958 0.75
163 Hemorrhagic diathesis associated with the presence of an anticoagulant in circulating blood; case report and laboratory studies. Blood 1948 0.75
164 [Modification of coagulation factors in plasma and preserved blood]. Sem Hop 1955 0.75
165 [New data concerning the anticoagulant action of a neodyme salt]. Rev Hematol 1957 0.75
166 [Hypoprothrombinemia secondary to dicoumarin therapy; shock due to prolonged vitamin K2 therapy and perfusions and spectacular cure with vitamin K1]. Sang 1952 0.75
167 [Not Available]. Prog Med (Paris) 1948 0.75
168 [Anticoagulants]. Rev Pathol Comp 1952 0.75
169 [New anticoagulants useful in therapy]. Vie Med 1956 0.75
170 [Adsorption of thrombin by particles of silica]. Pathol Biol (Paris) 1959 0.75
171 [New method for the determination of ionic calcium using a coagulating system]. Rev Fr Etud Clin Biol 1958 0.75
172 [Major blood eosinophilias]. Presse Med 1962 0.75
173 [Study of lipoproteins in human and experimental arteriosclerosis by electrophoresis and non-specific reactions of proteins; effect of heparin]. Sem Hop 1953 0.75
174 [Natural inhibitors of coagulation]. Sang 1959 0.75
175 [Polycythemia vera and the Budd-Chiari syndrome; clinical, biological & endoscopic study; traitement with P34 and tromexam; apparent recovery]. Rev Med Chir Mal Foie 1956 0.75
176 Anticoagulant activity of the trypsin inhibitor from soya bean flour. Proc Soc Exp Biol Med 1946 0.75
177 [Bentonite: a new adsorbant for coagulation factors]. Rev Fr Etud Clin Biol 1959 0.75
178 [Circulating anticoagulant of antithromboplastic activity]. Rev Fr Etud Clin Biol 1956 0.75
179 [Nonspecific reaction of proteins in pathology]. Rev Pathol Gen Physiol Clin 1954 0.75
180 [Recent data concerning the treatment of hemorrhagic syndromes]. Maroc Med 1962 0.75
181 [Extension of prothrombin time in relation to a deficit in "accelerin"]. Arch Fr Pediatr 1951 0.75
182 [Pancytopenia of splenic origin secondary to Banti's fibroadenia]. Sang 1951 0.75
183 [Heparin tolerance test in vitro in the control of dicumarol therapy]. Sang 1951 0.75
184 [Minimal technical conditions in preparation of human plasma fractions]. Rev Hyg Med Soc 1957 0.75
185 [Surveillance of heparin therapy. Evaluation of the dose of protamine to inject]. Presse Med 1959 0.75
186 [Therapeutic use of injectable fibrinogen; 1st accounts of its use in 33 patients]. Sang 1957 0.75
187 [Attempted electrophoretic identification of resorcidine]. Sang 1952 0.75
188 [List of blood products and preparation of blood derivatives (excluding gamma globulins)]. Sang 1956 0.75
189 [The neodymium index]. Rev Hematol 1958 0.75
190 [Scientific research in blood transfusion centers]. Rev Hyg Med Soc 1960 0.75
191 [Not Available]. Ann Biol Clin (Paris) 1949 0.75
192 [What degree of confidence can one give to laboratory methods for the prevention, diagnosis and treatment of venous thromboses?]. Presse Med 1960 0.75
193 [Correction in vitro of A and B hemophilia by various dilutions of normal blood: modifications of clotting time and of prothrombin consumption]. Sem Hop 1955 0.75
194 [Auto-transfusion]. Vox Sang 1961 0.75
195 [Etiological diagnosis of prolonged bleeding time]. Nouv Rev Fr Hematol 1963 0.75
196 [Present concept of blood coagulation]. Rev Prat 1951 0.75
197 [TRANSITORY RECURRENCE OF THROMBOPENIA FOLLOWING SPLENECTOMY]. Hemostase 1965 0.75
198 Study on the red cells sediment after clotting of polycythaemic blood. Tohoku Igaku Zasshi 1960 0.75
199 [Apropos of the posology of enzyme inhibitors]. Mem Acad Chir (Paris) 1961 0.75
200 [Conditions in which one should proceed in taking blood]. Rev Hyg Med Soc 1955 0.75
201 [Practical advice concerning the conduct of an anticoagulant treatment of a medical phlebitis]. Vie Med 1960 0.75
202 [The hemorrhagic syndrome of acute leukemias]. Sem Hop 1950 0.75
203 [Test of thermal flocculation of serum proteins (in 398 cases). Diagnostic value of the test in cancer, malignant hemopathy and tuberculosis]. Presse Med 1951 0.75
204 [Resistance to dicoumarins]. Pathol Biol (Paris) 1960 0.75